Position in PCRX
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$2,248,795
+$79,919 QoQ
Shares Held
88,640
-7.6% QoQ
Ownership
0.222%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#64
of 254 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in PCRX Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - Specialty & Generic
Healthcare · as of Jun 30, 2026Legal & General Group Plc holds $776,969,626 across 46 Drug Manufacturers - Specialty & Generic names. PCRX ranks #22 (0.3% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ZTS |
Zoetis Inc.
|
3,567,388 | $256,352,500 | |
| 2 | TEVA |
Teva Pharmaceutical Industries Ltd
|
3,916,666 | $132,696,643 | |
| 3 | UTHR |
UNITED THERAPEUTICS Corp
|
207,093 | $112,209,199 | |
| 4 | VTRS |
Viatris Inc
|
4,069,647 | $64,625,993 | |
| 5 | NBIX |
Neurocrine Biosciences Inc
|
314,451 | $52,997,570 | |
| 6 | ALKS |
Alkermes plc.
|
393,524 | $20,620,657 | |
| 7 | ELAN |
Elanco Animal Health Inc
|
711,233 | $17,503,443 | |
| 8 | XERS |
Xeris Biopharma Holdings, Inc.
|
2,012,792 | $15,941,311 |
All Filings in PCRX
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $2,248,795 | 88,640 | Shares | Defined | 2026-08-14 | |
| 2026-03-31 | $2,168,876 | 95,968 | Shares | Defined | 2026-05-08 | |
| 2025-12-31 | $2,893,046 | 111,787 | Shares | Defined | 2026-02-09 | |
| 2025-09-30 | $3,027,175 | 117,469 | Shares | Defined | 2025-11-13 | |
| 2025-06-30 | $3,087,210 | 129,172 | Shares | Defined | 2025-08-12 | |
| 2025-03-31 | $3,034,854 | 122,127 | Shares | Defined | 2025-05-15 | |
| 2024-12-31 | $2,370,994 | 125,849 | Shares | Defined | 2025-02-13 | |
| 2024-09-30 | $1,861,669 | 123,699 | Shares | Defined | 2025-02-28 | |
| 2024-06-30 | $3,605,774 | 126,032 | Shares | Defined | 2025-05-29 | |
| 2024-03-31 | $3,753,016 | 128,440 | Shares | Defined | 2025-05-29 | |
| 2023-12-31 | $4,327,795 | 128,269 | Shares | Defined | 2025-05-29 | |
| 2023-09-30 | $3,953,945 | 128,877 | Shares | Defined | 2023-11-14 | |
| 2023-06-30 | $5,287,837 | 131,965 | Shares | Defined | 2023-08-14 | |
| 2023-03-31 | $5,410,996 | 132,590 | Shares | Defined | 2023-05-15 | |
| 2022-12-31 | $5,126,751 | 132,783 | Shares | Defined | 2023-02-14 | |
| 2022-09-30 | $7,004,059 | 131,680 | Shares | Defined | 2022-11-14 | |
| 2022-06-30 | $7,686,329 | 131,841 | Shares | Defined | 2022-08-22 | |
| 2022-03-31 | $9,962,125 | 130,531 | Shares | Defined | 2022-05-16 | |
| 2021-12-31 | $7,647,907 | 127,105 | Shares | Defined | 2022-02-14 | |
| 2021-09-30 | $6,887,160 | 122,985 | Shares | Defined | 2021-11-15 | |
| 2021-06-30 | $6,874,739 | 113,295 | Shares | Defined | 2021-08-12 | |
| 2021-03-31 | $9,974,016 | 142,303 | Shares | Defined | 2021-05-17 | |
| 2020-12-31 | $8,236,915 | 137,649 | Shares | Defined | 2021-02-12 | |
| 2020-09-30 | $8,200,848 | 136,408 | Shares | Defined | 2020-11-13 | |
| 2020-06-30 | $7,053,069 | 134,421 | Shares | Defined | 2020-08-14 | |
| 2020-03-31 | $4,159,093 | 124,041 | Shares | Defined | 2020-05-14 | |
| No filing history on record for this holder in this stock. | ||||||